oa SA Pharmaceutical Journal - Cancer vaccines - where are we now? : review

Volume 77, Issue 7
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



Chronic infection with viruses, bacteria or parasites, has long been recognised as a major causative factor in the initiation and / or promotion of the development of cancers worldwide. This has led to research in the areas of immunotherapy and prophylactic immunisation in an effort to reduce the world's cancer burden. Cancer vaccines differ from other conventional methods of managing cancer such as chemotherapy and radiotherapy in that they initiate a process of activating the body's own immune system.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error